Neonatal bacillus Calmette-Guérin vaccination inhibits de novo allergic inflammatory response in mice via alteration of CD4 +CD25+ T-regulatory cells

Acta Pharmacologica Sinica

Volumn 30, Issue 1, 2009, Pages 125-133

  Li, Qian ^a,b   Shen, Hua Hao ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Allergic asthma; Bacillus Calmette Gu rin; CD25; CD4; T regulatory cell

Indexed keywords

BCG VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BCG VACCINATION; CD4+ CD25+ T LYMPHOCYTE; CONTACT INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; MOUSE; NEWBORN; NONHUMAN; REGULATORY T LYMPHOCYTE; SENSITIZATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; EOSINOPHIL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG LAVAGE; METABOLISM; SPLEEN;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD4; BCG VACCINE; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; EOSINOPHILS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 64849107635     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2008.3     Document Type: Article

References (52)

1. Moore WC. Update in asthma 2007. Am J Respir Crit Care Med 2008; 177: 1068-73.
2. Gould HJ, Suton BJ. IgE in allergy and asthma today. Nat Rev Immunol 2008; 8: 205-17.
3. Meyer EH, DeKruyff RH, Umetsu DT. T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med 2008; 59: 281-92.
4. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008; 8: 218-30.
5. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin response and atopic disorders. Science 1997; 275: 77-9.
6. Cui Y, Choi IS, Koh YA, Lin XH, Cho YB, Won YH. Effects of combined BCG and DHEA treatment in preventing the development of asthma. Immunol Invest 2008; 37: 191-202.
7. Erb KJ, Holloway JW, Sobeck A, Moll H, Gros GL. Infection of mice with Mycobacterium bovis-bacillus Calmete-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998; 187: 561-9.
8. Herz U, Gerhold K, Gruber C, Braun A, Wahn U, Renz H, et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998; 102: 867-74.
9. Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, et al. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol 2002; 169: 1492-9.
10. Shen H, Huang H, Wang J, Ye S, Li W, Wang K, et al. Neonatal vaccination with Bacillus Calmette-Guérin elicits long-term protection in mouse-allergic responses. Allergy 2008; 63: 555-63.
11. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
12. 8+ T cells. Proc Natl Acad Sci USA 2002; 99: 8832-7.
13. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-96.
14. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of the immune response. Immunol Rev 2005; 203: 156-64.
15. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfn, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27: 68-73.
16. + regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
17. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-7.
18. + regulatory T cells is mediated by cell surface-bound transforming growth factor-β. J Exp Med 2001; 194: 629-44.
19. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608-15.
20. + T cells protect against experimentally-induced asthma by altering the dendritic cell phenotype and activation state. J Exp Med 2005; 202: 1549-61.
21. + regulatory T cells is interleukin 10 dependent. J Exp Med 2005; 202: 1539-47.
22. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in tuberculosis patients. Am J Respir Crit Care Med 2006; 173: 803-10.
23. Hanekom WA. The immune response to BCG vaccination of newborns. Ann N Y Acad Sci 2005; 1062: 69-78.
24. +CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Microbes Infect 2007; 9: 1325-32.
25. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61.
26. Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT, et al. A causative relationship exists between eosino-phils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003; 170: 3296-305.
27. Wills-Karp M, Karp CL. Biomedicine. Eosinophils in asthma: remodeling a tangled tale. Science 2004; 305: 1726-9.
28. Ponsonby AL, Kemp A. Investigation of the hygiene hypothesis: current issues and future directions. Allergy 2008; 63: 506-8.
29. Holgate ST. The epidemic of allergy and asthma. Nature 1999; 402 (6760 Suppl): B2-4
30. Choi IS, Koh YI. Effects of BCG revaccination on asthma. Allergy 2003; 58: 1114-6.
31. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22: 329-41.
32. + regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol 2006; 84: 467-74.
33. 25+ regulatory T cells. Nat Med 2004; 10: 29-30.
34. + regulatory T cells increases bacterial clearance and improves survival in poly-micro bial sepsis. J Immunol 2005; 174: 7141-6.
35. + T cells during chronic hepatitis C virus infection. J Virol 2005; 79: 7860-7.
36. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin-2 production. J Exp Med 1998; 188: 287-96.
37. 8+ T cell responses. J Exp Med 2002; 196: 1585-92.
38. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183-90.
39. + regulatory T cells suppress differen tiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 2003; 170: 394-9.
40. + T cells. J Immunol 2002; 169: 3232-3.
41. + T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 2004; 172: 3842-9.
42. + regulatory T cells are dependent on CTLA-4 expression. Eur J Immunol 2004; 34: 3485-96.
43. + regulatory T cells abrogates their function in vivo. J Immunol 2006; 177: 4376-83.
44. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal infammation. J Exp Med 1999; 190: 995-1004.
45. + Treg. Eur J Immunol 2008; 38: 912-5.
46. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of IL-10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
47. McKarns SC, Leterio JJ, Kaminski NE. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro. Int Immunopharmacol 2003; 3: 1761-74.
48. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816-22.
49. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984-93.
50. van Kooyk Y, Engering A, Lekkerkerker AN, Ludwig IS, Geijtenbeek TB. Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr Opin Immunol 2004; 16: 488-93
51. + T cells in the control of inflammation. J Immunol 2003; 171: 5018-26.
52. + cells to develop suppressive activity: the role of IL-2, TGF-alpha, and IL-10. J Immunol 2004; 172: 5213-21.